Arseus Third-Quarter Sales Rise 23%; Company Confirms Forecasts

Arseus NV (RCUS), Europe’s largest supplier of ingredients to compounding pharmacies, said third-quarter sales rose 23 percent to 116.7 million euros.

The company confirmed its sales and profitability forecasts for the full year.

To contact the editor responsible for this story: Andrew Clapham at aclapham@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.